Yahoo Search Búsqueda en la Web

Entrar

Resultado de búsqueda

  1. uk.finance.yahoo.com › news › mesoblast-resubmits-biologics-license-applicationMesoblast Resubmits Biologics License Application (BLA) with...

    Hace 3 horas · NEW YORK, July 08, 2024 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, announced today it has resubmitted its BLA for approval of Ryoncil® (remestemcel-L) in the treatment of children with SR-aGVHD. The filing comes after Mesoblast was informed by FDA at the end of March that, following additional ...